Coronary artery bypass graft (CABG) surgery continues to be an important procedure for the treatment of coronary artery disease. However, clinically significant stenoses and complete bypass graft occlusion rates remain high, especially among saphenous vein grafts1. This is associated with significant morbidity and mortality. Both statin medications and aspirin have been shown in numerous clinical trials to play an important role in the medical management of coronary artery disease following CABG surgery. As per the ACC/AHA guidelines, both statin medications and aspirin have class I indications to support their use indefinitely following CABG, unless contraindication exists2. Long term studies evaluating statin and aspirin usage rates following CABG procedures are lacking.
The goal of this study was to assess the usage rates of statins and aspirin in post-CABG patients undergoing coronary angiograms. Further analysis was done to assess the clinical and laboratory differences among the populations based on medication usage group.
Recommended CitationCurl, MD, Kevin M.; Lebude, MD, Bryan; Ruggiero, MD, Nicholas; Fischman, MD, D L; Rose, MD, Andrew; Patel, MD, Sulay; Ogilby, MD, J. David; Walinsky, MD, Paul; Jasti, MD, Babu; and Savage, MD, Michael P., "Underutilization of Statins and Aspirin Following Coronary Artery Bypass Graft Surgery" (2014). Division of Cardiology Faculty Papers. Paper 43.